Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis

British Journal of Ophthalmology

Volumn 82, Issue 8, 1998, Pages 871-874

  Klok, Anne Marie ^a,b   Luyendijk, Leny ^a   Zaal, Michel J W ^b   Rothova, Aniki ^c   Hack, C Erik ^d,e   Kijlstra, Aize ^a,d  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HLA B27 ANTIGEN; INTERLEUKIN 8;

ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; HUMAN; INTERMEDIATE UVEITIS; MAJOR CLINICAL STUDY; PAPILLITIS; PHLEBITIS; PRIORITY JOURNAL;

EID: 0031705383     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.8.871     Document Type: Article

References (23)

1. Nussenblatt RB, Whitcup SM, Palestine AG. Uveitis: fundamentals and clinical practice. 2d ed. Chapter 20: Intermediate uveitis. St Louis: Mosby, 1996:279-88.
2. Malinowski SM, Folk JC, Pulido JS. Pars planitis. Curr Opin Ophthalmol 1994;5:72-82.
3. Smith RE, Godfrey WA, Kimura SJ. Chronic cyclitis. I. Course and visual prognosis. Trans Am Acad Opthalmol Otolaryngol 1973;77:760-8.
4. Henderly DE, Genstler AJ, Rao NA, et al. Pars planitis. Trans Ophthalmol Soc UK 1986;105:227-32.
5. Zierhut M, Foster CS. Multiple sclerosis, sarcoidosis and other diseases in patients with pars planitis. Dev Ophthalmol 1992;23:41-7.
6. Malinowski SM, Pulido JS, Folk JC. Long-term visual outcome and complications associated with pars planitis. Ophthalmology 1993;100:818-25.
7. Bamford CR, Ganley JP, Sibley WA, et al. Uveitis, perivenous sheating and multiple sclerosis. Neurology 1978; 28:119-24.
8. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15:81-8.
9. Kolb-Bachofen V. A review on the biological properties of C-reactive protein. Immunobiol 1991;183:133-45.
10. Kilpatrick JM, Volanakis JE. Molecular genetics, structure and function of C-reactive protein. Immunol Res 1991;10: 43-53.
11. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-9.
12. Hack CE, Hart M, Strack van Schijndel RJM, et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992;60:2835-42.
13. Yokoyama T, Kanda T, Kobayashi I, et al. Serum levels of interleukin-8 as a marker of disease activity in patients with chronic sarcoidosis. J Med 1995;26:209-19.
14. Mahida YR, Ceska M, Kurlak L, et al. Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci 1992;82:273-5.
15. de Boer JH, Hack CE, Verhoeven AJ, et al. Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid in uveitis and vitreoretinal disorders. Invest Ophthalmol Vis Sci 1993;34:3376-85.
16. Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987; 103:234-5.
17. Whicher JT, Dieppe PA. Acute phase proteins. Clin Immunol Allergy 1985;5:425-46.
18. Strieter RM, Kunkel SL, Einer VM, et al. Interleukin-8: a corneal factor that induces neo-vascularization. Am J Pathol 1992;141:1279-84.
19. Leonard EJ, Yoshima T. Neutrophil attractant/activation protein-1 (NAP-1[Inter leukin-8]). Am J Respir Cell Mol Biol 1990;2:479-86.
20. Einer VM, Strieter RM, Einer SG, et al. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am J Pathol 1990;136:745-50.
21. Arocker-Mettinger E, Steurer-Georgiew I, Steurer M, et al. Circulating ICAM-1 levels in serum of uveitis patients. Curr Eye Res 1992;11 (suppl):161-6.
22. Bora NS, Bora PS, Kaplan HJ. Identification, quantitation, and purification of a 36 kDa circulating protein associated with active pars planitis. Invest Ophthalmol Vis Sci 1996;37; 1870-6.
23. Tang WM, Pulido JS, Eckels DD, et al. The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol 1997;123:70-5.